Next Article in Journal
Editorial for the Special Issue: “Antibiotic Use in Clinical Infection: How to Reinvent Old Molecules and How to Squeeze out New Ones”
Next Article in Special Issue
Are Virulence and Antibiotic Resistance Genes Linked? A Comprehensive Analysis of Bacterial Chromosomes and Plasmids
Previous Article in Journal
Diversity of Monofloral Honey Based on the Antimicrobial and Antioxidant Potential
Previous Article in Special Issue
Genetic Determinants of Tigecycline Resistance in Mycobacteroides abscessus
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Antibiotics
Volume 11
Issue 5
10.3390/antibiotics11050596
antibiotics-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Genomic Analysis of Multidrug-Resistant Hypervirulent (Hypermucoviscous) Klebsiella pneumoniae Strain Lacking the Hypermucoviscous Regulators (rmpA/rmpA2)

by
Hisham N. Altayb
1,2,*,
Hana S. Elbadawi
3,
Othman Baothman
1,
Imran Kazmi
1,
Faisal A. Alzahrani
1,2,4,
Muhammad Shahid Nadeem
1,
Salman Hosawi
1,2 and
Kamel Chaieb
1,5
1
Department of Biochemistry, Faculty of Science, King Abdulaziz University, Jeddah 21589, Saudi Arabia
2
Centre for Artificial Intelligence in Precision Medicine, King Abdulaziz University, Jeddah 21589, Saudi Arabia
3
Microbiology and Parasitology Department, Soba University Hospital, University of Khartoum, Khartoum 11115, Sudan
4
King Fahd Medical Research Center, Embryonic Stem Cells Unit, Department of Biochemistry, Faculty of Science, King Abdulaziz University, Jeddah 21589, Saudi Arabia
5
Laboratory of Analysis, Treatment and Valorization of Pollutants of the Environmental and Products, Faculty of Pharmacy, University of Monastir, Monastir 5000, Tunisia
*
Author to whom correspondence should be addressed.
Antibiotics 2022, 11(5), 596; https://doi.org/10.3390/antibiotics11050596
Submission received: 21 March 2022 / Revised: 23 April 2022 / Accepted: 26 April 2022 / Published: 28 April 2022
(This article belongs to the Special Issue Genomic Analysis of Antibiotics Resistance in Pathogens)
Browse Figures
Versions Notes

Abstract

:
Hypervirulent K. pneumoniae (hvKP) strains possess distinct characteristics such as hypermucoviscosity, unique serotypes, and virulence factors associated with high pathogenicity. To better understand the genomic characteristics and virulence profile of the isolated hvKP strain, genomic data were compared to the genomes of the hypervirulent and typical K. pneumoniae strains. The K. pneumoniae strain was isolated from a patient with a recurrent urinary tract infection, and then the string test was used for the detection of the hypermucoviscosity phenotype. Whole-genome sequencing was conducted using Illumina, and bioinformatics analysis was performed for the prediction of the isolate resistome, virulome, and phylogenetic analysis. The isolate was identified as hypermucoviscous, type 2 (K2) capsular polysaccharide, ST14, and multidrug-resistant (MDR), showing resistance to ciprofloxacin, ceftazidime, cefotaxime, trimethoprim-sulfamethoxazole, cephalexin, and nitrofurantoin. The isolate possessed four antimicrobial resistance plasmids (pKPN3-307_type B, pECW602, pMDR, and p3K157) that carried antimicrobial resistance genes (ARGs) (blaOXA-1, blaCTX-M-15, sul2, APH(3″)-Ib, APH(6)-Id, and AAC(6′)-Ib-cr6). Moreover, two chromosomally mediated ARGs (fosA6 and SHV-28) were identified. Virulome prediction revealed the presence of 19 fimbrial proteins, one aerobactin (iutA) and two salmochelin (iroE and iroN). Four secretion systems (T6SS-I (13), T6SS-II (9), T6SS-III (12), and Sci-I T6SS (1)) were identified. Interestingly, the isolate lacked the known hypermucoviscous regulators (rmpA/rmpA2) but showed the presence of other RcsAB capsule regulators (rcsA and rcsB). This study documented the presence of a rare MDR hvKP with hypermucoviscous regulators and lacking the common capsule regulators, which needs more focus to highlight their epidemiological role.

1. Introduction

Klebsiella pneumoniae is a Gram-negative bacterium associated with invasive hospital-acquired infections [1]. Hypervirulent K. pneumoniae (hvKP) overproduces a polysaccharide capsule and is an important clinical pathogen responsible for several infections in healthy and immunosuppressed patients [2,3]. The presence of capsular polysaccharides (CPS) and lipopolysaccharides (LPS) are associated with organism dissemination and virulence [4]. This pathotype with hypermucoviscosity has acquired antimicrobial resistance capable of causing serious invasive disease, unlike the old drug-susceptible strains [3]. The presence of hvKP has been linked to endophthalmitis, pneumonia, liver abscesses, and meningitis [5]. The hvKP phenotype, which contributes to the hypermucoviscous phenotype, is related to the presence of a virulence plasmid containing two capsular polysaccharide regulator genes (rmpA and rmpA2) as well as multiple siderophore gene clusters and capsular K antigens (K1, K2, K5, K20, K54, and K57) [6,7]. Most of the hvKPs belong to a small collection of clonal groups; the more dominant groups are CG23 and include ST23, 26, 57, and 1633 [8].
Capsules, siderophores, lipopolysaccharides (LPS), fimbriae, outer membrane proteins, and type 6 secretion systems (T6SS) are among the virulence components that contribute to hvKP strains [9]. Most of the hypermucoviscous and hypervirulent strains of K. pneumoniae are characterized by the presence of the rmpA and rmpA2 (transcriptional activators, which regulate the mucoid phenotype) regulatory genes [10], but in a few cases, these strains could lack the rmpA and rmpA2 regulators [8,11].
Aerobactin is considered one of the most critical virulence factors in hvKP and is used for the definition of hypermucoviscous strains such as hvKP [6]. Aerobactin-producing isolates are more likely to cause a severe immune response in the host and more invasive infections [6]. In Taiwan, hypermucoviscosity was seen in 88.8% of K. pneumoniae isolates from individuals with pyogenic liver abscesses [12]. A purulent liver abscess caused by a very invasive community-acquired K. pneumoniae has recently been reported [3]. Furthermore, an outbreak of ST11-type carbapenem-resistant hvKP was reported in a Chinese hospital in 2016 [13].
Most of the hvKPs have remained susceptible to a variety of routinely used antimicrobial agents with the exception of ampicillin, but recently MDR isolates have been increasingly reported worldwide [14,15,16]. Carbapenem-resistant K. pneumoniae strains from the clonal group (CG) 258 are the most prevalent, with ST258 and ST11 being the most common multilocus sequence types globally [17]. The acquisition of virulence plasmids by K. pneumoniae harboring the insertion of the drug resistance genes blaKPC-2 and catA1 has been reported [18,19]. According to Hao et al. [3] the rates of the virulence-associated genes rmpA, iroB, fib, and hib were considerably greater in hvKP than in non-hvKP. Furthermore, plasmids carrying two replicons (IncHI1B–IncFIB and IncFIIK–IncFIBK) coding for drug-resistant and virulence genes were discovered [20,21]. The presence of a wide range of β-lactamases, aminoglycoside, and carbapenem-resistant genes could result in the increasing difficulty of treatment and long hospital stays [16,22]. More recently, hvKP belonging to ST147 in COVID-19 patients has been reported in Italy with three plasmid replicons of the IncFIB (Mar), IncR, and IncHI1B types as well as different resistance genes [23]. Additionally, fourteen colistin-resistant K. pneumoniae (CoRKp) strains were screened retrospectively in China between 2017 and 2018 [24]. Among them, six CoRKp strains belonging to ST11 were MDR [24].
Khartoum is one of the most crowded cities in Africa [25,26] which facilitates the horizontal transfer of antimicrobial-resistant bacteria. Additionally, Sudan suffers from the inappropriate use of antibiotics; most of the antibiotics are frequently sold over the counter and even without a medical prescription [27,28]. In a recent study conducted in Khartoum state, strains positive for β-lactamase and carbapenemase genes have been reported in hvKP isolates [29]. To better understand the genomic characteristics and virulence profile of the newly isolated hvKP strain (named 9KP), this comparative genomic study was conducted.

2. Results

2.1. Patient Details and Phenotypic Characterization of the Isolate

The isolate was obtained from a patient with CKD in Soba University Hospital in Sudan, and it was identified with a hypermucoviscous phenotype using the string test, in which mucus is measured more than 9 cm by lop (Supplementary file 1, Figure S1). The isolate was classified according to CLSI breakpoints as MDR when showing resistance to ciprofloxacin, ceftazidime, cefotaxime, trimethoprim-sulfamethoxazole, cephalexin, nitrofurantoin, amoxicillin-clavulanic acid, and ampicillin, while it was susceptible to meropenem, imipenem, amikacin, and gentamicin. A high resistance level was observed for cephalosporins and penicillin, in which a no inhibition zone (0 mm) was observed for amoxicillin-clavulanic acid and ampicillin. Additionally, for the first-generation and third-generation cephalosporins, a small zone of inhibition (10 mm) was observed. Among non-β-lactams, a high resistance level was observed for trimethoprim-sulfamethoxazole (0 mm) and a small zone of inhibition (10 mm) was observed with ciprofloxacin (Table 1).
For the determination of the minimum inhibitory concentrations (MIC) of the antibiotics, we used the microtitre broth dilution method, which revealed that the isolate possessed a high resistance level against ampicillin (MIC = 1024 μg/mL), tetracycline (MIC = 256 μg/mL), cefotaxime (MIC = 128 μg/mL), and ciprofloxacin (MIC = 128 μg/mL), while two antimicrobial (gentamicin and chloramphenicol) scored a very low MIC (4 μg/mL), falling within the susceptibility range according to CLSI guidelines [30] (Table 1).

2.2. Genome Characteristics and Typing

The total genome was assembled into 5364730 bp, with 83 contigs and an average contig length of 64635, while N50 was 220979, L50 7, the average coverage was 100X, and the GC content was 57.3%. The total number of predicted genes was 5248, 76 tRNA, and 202 genes associated with stress response, defense, and virulence (Supplementary file 1, Figure S2). The isolate was identified as K. pneumoniae with sequence type (ST) 14 by the Institut Pasteur MLST and MLST 2.0 databases. The global platform for genomic surveillance, Pathogenwatch, was used for the prediction of the capsule (K) and O serotypes; the isolate was identified with the K2 (wzi2 genotype) capsule and O1 serotype. The 9KP strain harbored ten antimicrobial resistance genes including β-lactam resistance genes (blaOXA-1, blaCTX-M-15, and blaSHV-28), sulfonamide resistance (sul2), fosfomycin resistance (fosA6), aminoglycoside resistance (APH(3″)-Ib, APH(6)-Id, and AAC(6′)-Ib-cr6), and the gene causing resistance to tetracycline (tet(A)). The chloramphenicol O-acetyltransferase (CatB3) gene was detected in the 9KP strain with 70% coverage and 100% identity (Supplementary file 1, Table S1). Additionally, three efflux pumps were identified, including K. pneumoniae KpnF, LptD, and oqxA. Two chromosomal mutations conferring resistance to fosfomycin (E350Q) and elfamycin EF-Tu (R234F) were also identified. The PlasmidFinder tool revealed the presence of four plasmid replicons (Col440II, IncFII, IncFIB(K), and IncFII(K)) in the 9KP strain with 100% identity and coverage. Additionally, the use of a BLASTn search against the PLSDB database revealed the presence of four plasmids in the 9KP strain, carrying different ARGs, pKPN3-307_type B, pECW602, pMDR, and p3K157, which showed a matching of 99.56%, 99.75%, 100%, and 100%, respectively. The pKPN3-307_type B plasmid of the K. pneumoniae strain H151440672 was identified in our strain as carrying genes corresponding to blaCTX-M-15, RND efflux, and IS1 sequences (Supplementary file 1, Figures S3 and S4). The Escherichia coli plasmid pECW602 was detected in the 9KP strain carrying different mobile elements and ARGs-encoding genes, which included sulfonamide (sul2) and aminoglycoside resistance genes (APH(3″)-Ib and APH(6)-Id) (Figure 1). K. pneumoniae pMDR was identified with two transposases capturing tet(A) MFS-family efflux-pump-encoding genes (Supplementary file 1, Figure S5). Moreover, we detected the chloramphenicol O-acetyltransferase (CatB3) gene, class D beta-lactamase (blaOXA-1), and aminoglycoside N(6′)-acetyltransferase (aac(6′)-Ib-cr) genes in the 9KP plasmid (p3K157) (Supplementary file 1, Figure S6) while SHV-28 and fosfomycin resistance (fosA6) genes were detected only in chromosomal sequences and were absent in the assembled plasmid, indicating their possible chromosomal association.
One plasmid belonging to the IncFIB(K) type was identified by a BLASTn search against PLSDB and showed 99.7% identity to the K. pneumoniae strain SCKP020143 plasmid p1_020143, and it was negative for ARGs (Supplementary file 1, Figure S7).
The virulence factor database was used for the prediction and comparison of the virulence genes of the 9KP strain with others. Different types of fimbrial proteins were discovered including type I (10), type 3 (8), and type IV pili (pilW) (Table 2) (Supplementary file 1, Table S2). A total of 15 iron uptake proteins were identified, including 1 aerobactin (iutA), 12 Ent siderophores, and 2 salmochelin, while it lacked the other aerobactin (iucA, iucB, iucC, and iucD) reported in the hvKP strains (NTUH-K2044 and KCTC 2242). The most closely related strains (kkp066 and kkp0e7) were positive for the hvKP marker, the RmpA gene, and lacked aerobactin (iucA, iucB, iucC, and iucD), similar to our strain. High similarity in the iron uptake system of 9KP and the other Sudanese strain (23KE) was observed, including the complete absence of genes related to yersiniabactin and the presence of two salmochelin and one aerobactin. Four secretion systems that are crucial virulence factors of pathogenic bacteria were identified in the 9KP strain, including T6SS-I (13), T6SS-II (9), T6SS-III (12), and one Sci-I T6SS exclusively detected in our strain. The isolate was positive for two RcsAB (rcsA and rcsB) regulatory proteins and one serum resistance LPS protein. The mediator of the hyper adherence YidE in enterobacteria and its conserved region were predicted in the isolate.

2.3. Comparative Genomics and Phylogenomics Analysis

After the genome comparison, the species formed 6142 protein clusters, 3185 orthologous, and 2957 single-copy gene clusters. 9KP showed 192 single-copy genes and 4843 proteins clustered with others (Supplementary file 1, Table S3). A high degree of variability was observed at different chromosomal regions of 9KP, which contains ARGs, incF plasmid proteins, IS, and other mobile elements.
Comparative genomics revealed that the strains TCC BAA-2146, 23KE, kkp066, kkp0e6, and NTUH-K2044 exhibited a high similarity to 9KP, in which different virulent regions were similar, such as the outer membrane protein OmpN, LysR-type transcriptional regulators, kinase, and fimbrial proteins (Figure 2) detected at a region located between the chromosomal range 1.5–1.6 Mb. Ferric enterobactin-related proteins and phage-related proteins were clustered in K. pneumoniae 9KP similarly to the strains ATCC BAA-2146 and NTUH-K2044 (Figure 3), while the secretion systems T6SS were located in a region adjacent to the VgrG protein, transposases, putative kinase, mobile elements, transcriptional regulator, LysR family, and phage proteins. The PTS system in the 9KP strain was most similar to the PTS system of the 23KE strain from Sudan others (Supplementary file 1, Figure S3, and Supplementary file 2).
A phylogenetic tree was generated among the African strains by the iTOL—Interactive Tree of Life—Klebsiella Pasteur MLST database. The 9KP strain was clustered in a clade containing three strains from Kenya, one was isolated from a patient with a soft tissue infection (kkp066) and the others (kkp0e6 and kkp0e7) were isolated from hospital environment. And it was also clustered to one MDR Sudanese strain (K23) isolated from drinking water in Khartoum state (Figure 4).

3. Discussion

Hypervirulent K. pneumoniae strains possess distinct morphological and genotypic characteristics when compared to other classical strains, which include the production of colonies with hypermucoviscosity, unique serotypes, and virulence factors associated with high pathogenicity [31]. Except for ampicillin, most of the hvKPs have remained susceptible to a variety of routinely used antimicrobial drugs, but recently MDR isolates have been increasingly reported worldwide [14,15,16]. The present study reported MDR hvKP in a patient with a recurrent UTI, and it harbored genes conferring resistance to β-lactam (blaOXA-1, blaCTX-M-15, and blaSHV-28), sulfonamide (sul2), fosfomycin (fosA6), and aminoglycoside (APH(3″)-Ib, APH(6)-Id, and AAC(6′)-Ib-cr6). The presence of a wide range of β-lactamases and aminoglycoside-resistant genes could result in the increased difficulty of treatment and long hospital stays [16,22]. Klebsiella species are known to have intrinsic resistance to ampicillin [32], and here we reported a very high resistance level to ampicillin (MIC ≥ 1024 μg/mL). This could be a result of the presence of additional beta-lactamases (blaCTX-M-15, blaOXA-1, and blaSHV-28). A high resistance level was also observed against cefotaxime (MIC ≥ 128 μg/mL), which could be attributed to the presence of blaCTX-M-15 which possesses a high hydrolytic activity against cefotaxime [33]. Although the isolate harbored chloramphenicol O-acetyltransferase (CatB3), the isolate was highly susceptible to chloramphenicol. This could be due to the truncation of the gene, which only showed 70% coverage to the references.
Our isolate harbored an IncF plasmid, insertion sequences, and phage-associated proteins at regions containing ARGs and virulence genes, which reflect their possible role in the horizontal gene transfer and dissemination of such strains [16]. The IncF plasmids are thought to play a significant role in the acquisition of MDR genes [34,35], which could increase the chance for the acquisition of genes such as the blaKPC carbapenem resistance gene.
We identified four plasmids that carried different ARGs and transposases. The presence of the ARGs plasmids in the hvKP strain, which is known to be a more drug-susceptible strain [36], could be a reason for the presence of the MDR phenomenon in our isolate. Additionally, these plasmids may result in the mobility of these ARGs to drug-susceptible isolates.
Our isolate harbored a pKPN3-307_type B plasmid that carried genes corresponding to blaCTX-M-15, RND efflux, and IS1 sequences; similar plasmids carrying blaCTX-M-15 with transposases have been reported in the KPC-producing K. pneumoniae ST307 strain in the UK [37]. The presence of the CTX-M gene in the mobile elements could be the reason for the current dissemination of the CTX-M-positive isolates in our region [38,39]. Moreover, the isolate possessed the heavy metal (copper(I)/silver(I)) efflux pump (RND efflux); isolates resistant to silver have more affinity to establishing hospital and environmental outbreaks [40]. Interestingly, the 9KP strain harbored the plasmid pECW602, which is a novel plasmid reported recently in an extensively drug-resistant (XDR) E. coli isolate in China [41]; here we reported it for the first time in a K. pneumoniae (9KP) isolate with high identity (99.75%) and high coverage (744). The 9KP plasmid (pECW602) and E. coli pECW602 plasmid carried a similar pattern regarding the presence of sulfonamide (sul2) and aminoglycoside resistance genes (APH(3″)-Ib and APH(6)-Id). The gene responsible for the resistance to tetracycline (tetA) associated with the MFS family efflux pump was identified in the K. pneumoniae 9KP strain pMDR plasmid; the gene expression of the MFS-type tetA has been documented in different Gram-negative isolates [42,43]. tet(A)-bearing K. pneumoniae was reported with a high tetracycline and tigecycline resistance level [42]. Adding to that, another tetracycline resistance efflux (oqxA) was discovered in our isolate [44]. In addition to plasmid-mediated ARGs, two genes (fosA6 and SHV-28) were not detected among the assembled plasmids of the 9KP strain but they were present in the chromosomes; the fosfomycin resistance gene (fosA6) and the broad spectrum B-lactamase SHV-28 gene are commonly reported in K. pneumoniae chromosomes [45,46,47,48].
The isolate lacked the common regulators of the hypermucoviscous phenotype (rmpA/rmpA2) [49] and yersiniabactin system but showed the presence of aerobactin-(iutA) and salmochelin-(iroE and iroN) encoding genes, which are clear markers for hvKP identification [50]. Additionally, the strain was predicted with the K2 capsule type and hypermucoviscosity, which are common virulence factors in hvKP [51]. Similarly, strains belonging to hvKP and lacking the rmpA and rmpA2 genes were previously reported without knowledge of the mechanisms of capsule overexpression [52,53]. One possible explanation of the mucoviscosity in K. pneumoniae 9KP is the presence of the RcsA and RcsB genes; the RcsA gene binds with RcsB to activate the genes responsible for capsular polysaccharide production in E. coli [54]. Another explanation for the presence of the siderophore receptors without biosynthetic genes in hvKP is that these strains can acquire the siderophores from other bacteria found in the same environment [8]. Similar to our finding, a highly virulent and invasive K. pneumoniae strain possessing genes such as aerobactin (iutA), hypermucoviscosity, salmochelin, and lacking rmpA/rmpA2 was reported in a patient suffering from necrotizing soft tissue infection at Northwestern Memorial Hospital, USA [51].
In this study, four T6SS systems were detected. The type VI secretion system (T6SS) is usually located at the chromosomes or pathogenicity islands of virulent bacteria, and they have a role in host infection and colonization [55]. Additionally, eight type 3 fimbrial proteins were reported. Usually, isolates that express type 3 fimbriae are more biofilm-producing compared to other strains [56]. Biofilm-producing isolates can cause community or hospital infections and are associated with 65% of microbial infections and 80% of chronic infections globally [57]. Furthermore, the genomic analysis of the K. pneumoniae 9KP strain demonstrated a large abundance of LysR-family transcriptional regulators in the genomic regions containing a cluster of virulence and antimicrobial resistance genes. LysR is found in different bacterial species and has a role in the regulation of virulence factors in pathogenic bacteria [58]. A novel type of the LysR family has been demonstrated to have a pleiotropic role in mediating the resistance and increasing the virulence of the hvKP NTUH-K2044 strain [59].
The phylogenetic analysis showed that the 9KP strain is more related to strains from Kenya and Sudan. This could be due to the fact that Kenya is a neighboring country to Sudan, and the Sudanese clustered isolate was from the same location (Khartoum) of the sample collection in our study. Two of the Kenyan strains (kkp066 and kkp0e7) were hvKPs possessing the RmpA gene and lacked aerobactins (iucA, iucB, iucC and iucD), similar to our strain. Additionally, the 9KP strain showed a high similarity in the PTS system to the 23KE strain from Sudan. This could be one of the reasons behind their high similarity to our strain.
MDR and hvKP strains previously developed in distinct clonal groups [60] but the recent emergence of hvKP isolates carrying MDR genes needs more attention. Such a strain has the potential to produce fatal hospital outbreaks, so more focus is needed to highlight its epidemiological role.

4. Methods

4.1. Bacterial Isolation, Identification, Susceptibility Testing, and DNA Extraction

Klebsiella spp. was isolated from the urine sample of a 40-year-old male patient with a history of recurrent UTI, hypertension, and chronic kidney disease (CKD) admitted for hemodialysis in Soba Hospital, Khartoum in July 2021. The patient was visiting the dialysis unit regularly 2 times in a week; the patient received a course of ciprofloxacin twice daily for 3 days without a response. The bacterium was isolated using a MacConkey and blood agar (HiMedia, Mumbai, India), then was identified using routine conventional microbiology methods [61] and Chromogenic UTI media (bioMérieux, Lyon, France). The isolate was identified as a hypermucoviscous strain using the string test [62]. Antimicrobial susceptibility testing was performed using the disk diffusion method to test the activity of amoxicillin-clavulanate (30 µg), cefuroxime (30 µg), ceftriaxone (30 µg), ceftazidime (30 µg), cephalexin (30 µg), meropenem (10 µg), imipenem (10 µg), amikacin (30 µg), gentamicin (10 µg), ciprofloxacin (5 µg), trimethoprim-sulfamethoxazole (25 µg), and nitrofurantoin (300 μg). K. pneumoniae ATCC 700603 was used for testing the quality of the culture media, antibiotic disc, and MIC. CLSI guidelines [30] were used for the susceptibility test results interpretation. DNA was extracted using the quinidine chloride protocol [63]. The gel electrophoresis and Nanodrop, Qubit (Thermo Scientific TM, Carlsbad, CA, USA), were used for the estimation of the integrity and quantification of the extracted DNA.

4.2. Minimum Inhibitory Concentration (MIC)

The microtitre broth dilution method [64] was used to determine the minimum inhibitory concentration of ciprofloxacin, gentamicin, cefotaxime, ampicillin, chloramphenicol, and tetracycline. A two-fold serial dilution of the antibiotics was prepared in Muller–Hinton (MH) broth, and 100 μL of overnight-grown bacteria adjusted to 5–105 CFU/mL was poured into each well. The antibiotics concentration used was in the range of 2 to 1024 μg/mL [65]. MIC results were interpreted according to CLSI guidelines [30].

4.3. Genome Sequencing and Assembly

Whole-genome sequencing was conducted by Novogene Company (Beijing, China) using HiSeq 2500 platform (Illumina, San Diego, CA, USA). The generated short reads (2 × 150 bp) were assembled into contigs using a de novo assembly of Velvet v. 1.2.10 [66]; then, reads with low quality and less than 200 bp were removed. The assembled sequences were submitted to GenBank under bioproject (PRJNA767482), biosample (SAMN26332310), and accession number JAKWFM000000000, and were assigned the 9KP strain. The isolate was identified using MLST 2.0 and the Pasteur MLST. The PATRIC web server and the NCBI Prokaryotic Genome Annotation Pipeline (PGAP) [67] were used for genome annotation.

4.4. Plasmid Assembly and Identification

The plasmidSPAdes tool v3.15.4 [68] was used for the assembly of the putative plasmids sequences from the illumine short read, using different k-mer sizes (21, 33, and 55). The generated plasmids were further evaluated by the Plasmid Finder 2.1 tool using 95% identity and 60% coverage. Additionally, the generated plasmids were aligned using BLASTn against the plasmid sequences obtained from the plasmid database (PLSDB); then, a local database of the obtained plasmids was generated at OmicsBox v2.1, and a local blast search was used for the identification of the plasmids. A plasmid circular map was generated by the SnapGene Viewer 6.0.2 software.

4.5. Identification of Antimicrobial-Resistant Genes (ARGs) and Mobile Elements

To identify plasmid-mediated ARGs, the generated plasmids were submitted to the Resistance Gene Identifier (RGI) 5.2.1 and ResFinder 4.0 [69] databases; hits with ≥95% identity and ≥98% coverage were accepted. Furthermore, ResFinder 4.0 was used to detect chromosomal mutations conferring resistance to antibiotics; this tool contains a hit that can be flagged to indicate whether the hit is a plasmid or chromosomally mediated. Insertion sequences (IS) were identified by an IS Finder.

4.6. Prediction and Comparison of Virulence Genes

The virulence factors of the hvKP strain were screened using RAST 2.0 and the virulence factor database (VFDB) [70]. The capsule-type genes were identified using the Kleborate v2.2.0 [71] and Pathogenwatch database. The isolate (9KP) virulence profile was compared to a list of K. pneumoniae strains including the most closely related strains (23KE, kkp066, kkp0e6, and kkp0e7) and those found in the VFDB database which includes K. pneumoniae 342, MGH78578, NTUH-K2044, 1084, HS11286, KCTC 2242, and SB3432; among these strains, two (NTUH-K2044 and KCTC 2242) were hvKP [72]. SnapGene Viewer v.6.0.2 (GSL Biotech; available at snapgene.com, accessed on 20 March 2022) was used for the visualization of the virulence genes cassettes.

4.7. Comparative Genomics and Phylogenetic Analysis

The PATRIC v3.6.12 proteome comparison tool [73] was used to perform a protein-sequence-based genome comparison using bidirectional BLASTp. The OrthoVenn2 server [74] was used for protein orthologous clustering analysis. The most closely related genomes (23KE, kkp066, and kkp0e7) and the commonly used strains (K. pneumoniae BAA2146, HS11286, MGH78578, NTUH-K2044, NUHL24835, and PittNDM01) for K. pneumoniae genome comparison [31,75,76] were used as references. The phylogenetic tree was generated and visualized by the online Interactive Tree of Life (iTOL v6) tool available at Pasteur MLST. This tool generates neighbor-joining trees from concatenated nucleotide sequences; we considered all loci that contained allele sequence identifiers and cgMLST schemes for tree generation. The tree was generated against the most similar African strains of K. pneumoniae submitted to the Pasteur MLST database.

5. Conclusions

This study documented the presence of a rare MDR hvKP, K. pneumoniae 9KP, belonging to K2 and ST14 with hypermucoviscous; it lacked the yersiniabactin system and the common regulators (rmpA/rmpA2) of the hypermucoviscous but showed the presence of other capsule regulators, such as RcsAB (rcsA and rcsB) and aerobactin (iutA), as well as the presence of salmochelin-(iroE, iroN) encoding genes, which are clear markers for hvKP identification.
The MIC revealed that the isolate possessed a high resistance level against ampicillin (1024 μg/mL), tetracycline (256 μg/mL), cefotaxime (128 μg/mL), and ciprofloxacin (128 μg/mL).
The isolate possessed four antimicrobial resistance plasmids (pKPN3-307_type B, pECW602, pMDR, and p3K157) that carried different ARGs and transposases, indicating their possible horizontal transfer and the clonal spread. The pECW602 plasmid is a novel plasmid reported recently in an extensively drug-resistant (XDR) E. coli isolate in China [41]; here, for the first time, we reported it in a K. pneumoniae (9KP) isolate with high identity (99.75%).

Supplementary Materials

The following are available online at https://www.mdpi.com/article/10.3390/antibiotics11050596/s1, Supplementary file 1: contains Tables S1–S3, representing ARGs (Table S1), virulence factors (Table S2), and numbers of the clustered and singletons proteins in the 9KP strain compared to others (Table S3). Additionally, it contains figures from Figures S1–S7 representing the string test photograph (Figure S1), a pie chart of the annotated subsystem and genes of K. pneumoniae 9KP (Figure S2), a circular map of the whole-genome comparison of the 9KP strain to different K. pneumoniae strains (Figure S3), and a map of the K. pneumoniae strain 9PK plasmids (Figures S4–S7),). Supplementary file 2: contains the complete data of the whole-genome comparison of the 9KP strain to different K. pneumoniae strains.

Author Contributions

H.N.A.: conceptualization, supervision, bioinformatics analysis, writing—review and editing, and funding acquisition. H.S.E.: data acquisition, carried out the microbiological analysis, writing—review and editing. O.B. and I.K.: methodology, software, data curation, formal analysis, writing—review and editing, F.A.A.: methodology, software, data curation, writing—review and editing. M.S.N.: methodology, analysis, writing—review and editing. S.H.: investigations, resources, writing—review and editing. K.C.: validation, supervision, visualization, writing—review and editing. All authors have read and agreed to the published version of the manuscript.

Funding

The authors extend their appreciation to the Deputyship for Research & Innovation; Ministry of Education in Saudi Arabia, for funding this research work through the project number IFPRC-072-130-2020; and King Abdulaziz University DSR, Jeddah, Saudi Arabia.

Institutional Review Board Statement

This study was approved by the Ethics Committee of the Khartoum State Ministry of Health (REF: 2/2021).

Informed Consent Statement

Not applicable because we were collecting sample remnants without the patient’s identifiable information.

Data Availability Statement

The data for this project was submitted to GenBank under the Bioproject PRJNA767482 and in the additional files.

Acknowledgments

The authors extend their appreciation to the Deputyship for Research & Innovation; Ministry of Education in Saudi Arabia, for funding this research work through the project number IFPRC-072-130-2020; and King Abdulaziz University DSR, Jeddah, Saudi Arabia.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Meatherall, B.L.; Gregson, D.; Ross, T.; Pitout, J.D.; Laupland, K.B. Incidence, risk factors, and outcomes of Klebsiella pneumoniae bacteremia. Am. J. Med. 2009, 122, 866–873. [Google Scholar] [CrossRef] [PubMed]
  2. Li, P.; Liang, Q.; Liu, W.; Zheng, B.; Liu, L.; Wang, W.; Xu, Z.; Huang, M.; Feng, Y. Convergence of carbapenem resistance and hypervirulence in a highly-transmissible ST11 clone of K. pneumoniae: An epidemiological, genomic and functional study. Virulence 2021, 12, 377–388. [Google Scholar] [CrossRef] [PubMed]
  3. Hao, Z.; Duan, J.; Liu, L.; Shen, X.; Yu, J.; Guo, Y.; Wang, L.; Yu, F. Prevalence of community-acquired, hypervirulent Klebsiella pneumoniae isolates in Wenzhou, China. Microb. Drug Resist. 2020, 26, 21–27. [Google Scholar] [CrossRef] [PubMed]
  4. Hsieh, P.-F.; Lin, T.-L.; Yang, F.-L.; Wu, M.-C.; Pan, Y.-J.; Wu, S.-H.; Wang, J.-T. Lipopolysaccharide O1 antigen contributes to the virulence in Klebsiella pneumoniae causing pyogenic liver abscess. PLoS ONE 2012, 7, e33155. [Google Scholar]
  5. Shon, A.S.; Bajwa, R.P.; Russo, T.A. Hypervirulent (hypermucoviscous) Klebsiella pneumoniae: A new and dangerous breed. Virulence 2013, 4, 107–118. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  6. Liu, C.; Guo, J. Hypervirulent Klebsiella pneumoniae (hypermucoviscous and aerobactin positive) infection over 6 years in the elderly in China: Antimicrobial resistance patterns, molecular epidemiology and risk factor. Ann. Clin. Microbiol. Antimicrob. 2019, 18, 1–11. [Google Scholar] [CrossRef] [Green Version]
  7. Alcántar-Curiel, M.D.; Girón, J.A. Klebsiella Pneumoniae and the Pyogenic Liver Abscess: Implications and Association of the Presence of rpmA Genes and Expression of Hypermucoviscosity. Virulence 2015, 6, 407–409. [Google Scholar] [CrossRef] [Green Version]
  8. Choby, J.; Howard-Anderson, J.; Weiss, D. Hypervirulent Klebsiella pneumoniae—Clinical and molecular perspectives. J. Intern. Med. 2020, 287, 283–300. [Google Scholar] [CrossRef] [Green Version]
  9. Lan, Y.; Zhou, M.; Li, X.; Liu, X.; Li, J.; Liu, W. Preliminary Investigation of Iron Acquisition in Hypervirulent Klebsiella pneumoniae Mediated by Outer Membrane Vesicles. Infect. Drug Resist. 2022, 15, 311. [Google Scholar] [CrossRef]
  10. Shankar, C.; Basu, S.; Lal, B.; Shanmugam, S.; Vasudevan, K.; Mathur, P.; Ramaiah, S.; Anbarasu, A.; Veeraraghavan, B. Aerobactin Seems To Be a Promising Marker Compared With Unstable RmpA2 for the Identification of Hypervirulent Carbapenem-Resistant Klebsiella pneumoniae: In Silico and In Vitro Evidence. Front. Cell. Infect. Microbiol. 2021, 11, 709681. [Google Scholar] [CrossRef]
  11. Yu, W.-L.; Lee, M.-F.; Tang, H.-J.; Chang, M.-C.; Chuang, Y.-C. Low prevalence of rmpA and high tendency of rmpA mutation correspond to low virulence of extended spectrum β-lactamase-producing Klebsiella pneumoniae isolates. Virulence 2015, 6, 162–172. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  12. Ku, Y.-H.; Chuang, Y.-C.; Yu, W.-L. Clinical spectrum and molecular characteristics of Klebsiella pneumoniae causing community-acquired extrahepatic abscess. J. Microbiol. Immunol. Infect. 2008, 41, 311–317. [Google Scholar] [PubMed]
  13. Gu, D.; Dong, N.; Zheng, Z.; Lin, D.; Huang, M.; Wang, L.; Chan, E.W.-C.; Shu, L.; Yu, J.; Zhang, R. A fatal outbreak of ST11 carbapenem-resistant hypervirulent Klebsiella pneumoniae in a Chinese hospital: A molecular epidemiological study. Lancet Infect. Dis. 2018, 18, 37–46. [Google Scholar] [CrossRef]
  14. Tang, M.; Kong, X.; Hao, J.; Liu, J. Epidemiological characteristics and formation mechanisms of multidrug-resistant hypervirulent Klebsiella pneumoniae. Front. Microbiol. 2020, 11, 2774. [Google Scholar] [CrossRef] [PubMed]
  15. Shankar, C.; Santhanam, S.; Kumar, M.; Gupta, V.; Devanga Ragupathi, N.K.; Veeraraghavan, B. Draft genome sequence of an extended-spectrum-β-lactamase-positive hypervirulent Klebsiella pneumoniae strain with novel sequence type 2318 isolated from a neonate. Genome Announc. 2016, 4, e01273-16. [Google Scholar] [CrossRef] [Green Version]
  16. Hao, M.; Shi, X.; Lv, J.; Niu, S.; Cheng, S.; Du, H.; Yu, F.; Tang, Y.-W.; Kreiswirth, B.N.; Zhang, H. In vitro activity of apramycin against carbapenem-resistant and hypervirulent Klebsiella pneumoniae isolates. Front. Microbiol. 2020, 11, 425. [Google Scholar] [CrossRef] [Green Version]
  17. Chen, L.; Mathema, B.; Chavda, K.D.; DeLeo, F.R.; Bonomo, R.A.; Kreiswirth, B.N. Carbapenemase-producing Klebsiella pneumoniae: Molecular and genetic decoding. Trends Microbiol. 2014, 22, 686–696. [Google Scholar] [CrossRef] [Green Version]
  18. Chen, Y.; Marimuthu, K.; Teo, J.; Venkatachalam, I.; Cherng, B.P.Z.; De Wang, L.; Prakki, S.R.S.; Xu, W.; Tan, Y.H.; Nguyen, L.C. Acquisition of plasmid with carbapenem-resistance gene blaKPC2 in hypervirulent Klebsiella pneumoniae, Singapore. Emerg. Infect. Dis. 2020, 26, 549. [Google Scholar] [CrossRef] [Green Version]
  19. Shankar, C.; Jacob, J.J.; Vasudevan, K.; Biswas, R.; Manesh, A.; Sethuvel, D.P.M.; Varughese, S.; Biswas, I.; Veeraraghavan, B. Emergence of multidrug resistant hypervirulent ST23 Klebsiella pneumoniae: Multidrug resistant plasmid acquisition drives evolution. Front. Cell. Infect. Microbiol. 2020, 10, 575289. [Google Scholar] [CrossRef]
  20. Lam, M.M.; Wyres, K.L.; Wick, R.R.; Judd, L.M.; Fostervold, A.; Holt, K.E.; Löhr, I.H. Convergence of virulence and MDR in a single plasmid vector in MDR Klebsiella pneumoniae ST15. J. Antimicrob. Chemother. 2019, 74, 1218–1222. [Google Scholar] [CrossRef] [Green Version]
  21. Turton, J.; Davies, F.; Turton, J.; Perry, C.; Payne, Z.; Pike, R. Hybrid resistance and virulence plasmids in “high-risk” clones of Klebsiella pneumoniae, including those carrying blaNDM-5. Microorganisms 2019, 7, 326. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  22. Navon-Venezia, S.; Kondratyeva, K.; Carattoli, A. Klebsiella pneumoniae: A major worldwide source and shuttle for antibiotic resistance. FEMS Microbiol. Rev. 2017, 41, 252–275. [Google Scholar] [CrossRef] [PubMed]
  23. Falcone, M.; Tiseo, G.; Arcari, G.; Leonildi, A.; Giordano, C.; Tempini, S.; Bibbolino, G.; Mozzo, R.; Barnini, S.; Carattoli, A.; et al. Spread of hypervirulent multidrug-resistant ST147 Klebsiella pneumoniae in patients with severe COVID-19: An observational study from Italy, 2020–2021. J. Antimicrob. Chemother. 2022, 77, 1140–1145. [Google Scholar] [CrossRef] [PubMed]
  24. Liu, X.; Wu, Y.; Zhu, Y.; Jia, P.; Li, X.; Jia, X.; Yu, W.; Cui, Y.; Yang, R.; Xia, W. Emergence of colistin-resistant hypervirulent Klebsiella pneumoniae (CoR-HvKp) in China. Emerg. Microbes Infect. 2022, 11, 648–661. [Google Scholar] [CrossRef] [PubMed]
  25. Elhadary, Y.; Ali, S. A new trend in urban housing: Gated communities in Khartoum, Sudan. Am. J. Sociol. Res. 2017, 7, 45–55. [Google Scholar]
  26. Gatari, M. Air pollution over East Africa. In Proceedings of the Oral Presentation, First International Workshop on Climate Variability over Africa, Alexandria, Egypt, 15–26 May 2005. [Google Scholar]
  27. Alamin, A.S.A.; Kheder, S.I. Knowledge, Attitudes and Practices of Prescribers towards Antimicrobial Stewardship at Hospitals in Khartoum State—Sudan. J. Med. Inform. Decis. Mak. 2020, 1, 12–25. [Google Scholar] [CrossRef]
  28. Musa, M.M.Y.A. Medicine Prices, Availability and Affordability in Sudan; Partial fulfillment of MSc of Health Economics and Health Care Management; Chulalongkorn University: Bangkok, Thailand, 2013. [Google Scholar]
  29. Albasha, A.M.; Abd-Alhalim, S.; Alshaib, E.F.; Al-Hassan, L.; Altayb, H.N. Detection of several carbapenems resistant and virulence genes in classical and hyper-virulent strains of Klebsiella pneumoniae isolated from hospitalized neonates and adults in Khartoum. BMC Res. Notes 2020, 13, 312. [Google Scholar] [CrossRef]
  30. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Thirtieth Informational Supplement; Document M100-S130 CLSI; Clinical and Laboratory Standards Institute: Wayne, PA, USA, 2020. [Google Scholar]
  31. Du, L.; Zhang, J.; Liu, P.; Li, X.; Su, K.; Yuan, L.; Zhang, Z.; Peng, D.; Li, Y.; Qiu, J. Genome sequencing and comparative genome analysis of 6 hypervirulent Klebsiella pneumoniae strains isolated in China. Arch. Microbiol. 2021, 203, 3125–3133. [Google Scholar] [CrossRef]
  32. Bouza, E.; Cercenado, E. Klebsiella and enterobacter: Antibiotic resistance and treatment implications. Semin. Respir. Infect. 2002, 17, 215–230. [Google Scholar] [CrossRef]
  33. Soge, O.O.; Queenan, A.M.; Ojo, K.K.; Adeniyi, B.A.; Roberts, M.C. CTX-M-15 extended-spectrum β-lactamase from Nigerian Klebsiella pneumoniae. J. Antimicrob. Chemother. 2006, 57, 24–30. [Google Scholar] [CrossRef] [Green Version]
  34. Huang, Q.-S.; Liao, W.; Xiong, Z.; Li, D.; Du, F.-L.; Xiang, T.-X.; Wei, D.; Wan, L.-G.; Liu, Y.; Zhang, W. Prevalence of the NTEKPC-I on IncF plasmids among Hypervirulent Klebsiella pneumoniae isolates in Jiangxi Province, South China. Front. Microbiol. 2021, 12, 622280. [Google Scholar] [CrossRef] [PubMed]
  35. Du, P.; Liu, C.; Fan, S.; Baker, S.; Guo, J. The Role of Plasmid and Resistance Gene Acquisition in the Emergence of ST23 Multi-Drug Resistant, Hypervirulent Klebsiella pneumoniae. Microbiol. Spectr. 2022, 21, e0192921. [Google Scholar] [CrossRef] [PubMed]
  36. Marr, C.M.; Russo, T.A. Hypervirulent Klebsiella pneumoniae: A new public health threat. Expert Rev. Anti-Infect. Ther. 2019, 17, 71–73. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  37. Ludden, C.; Moradigaravand, D.; Jamrozy, D.; Gouliouris, T.; Blane, B.; Naydenova, P.; Hernandez-Garcia, J.; Wood, P.; Hadjirin, N.; Radakovic, M. A One Health study of the genetic relatedness of Klebsiella pneumoniae and their mobile elements in the East of England. Clin. Infect. Dis. 2020, 70, 219–226. [Google Scholar] [CrossRef] [Green Version]
  38. Saeed Mohammed, S.A.; Musa, A.; Ahmed Mohammed, A.; Mohammed, H. CTX-M Β-lactamase–producing Escherichia coli in sudan tertiary hospitals: Detection genotypes variants and bioinformatics analysis. Int. J. Med. Biomed. Stud. 2019, 3, 146–157. [Google Scholar]
  39. Altayb, H.N.; Salih, E.K.; Moglad, E.H. Molecular detection of beta-lactamase blaCTX-M group 1 in Escherichia coli isolated from drinking water in Khartoum State. J. Water Health 2020, 18, 1091–1097. [Google Scholar] [CrossRef] [PubMed]
  40. Sütterlin, S. Aspects of Bacterial Resistance to Silver; Acta Universitatis Upsaliensis: Uppsala, Switzerland, 2015. [Google Scholar]
  41. Wang, M.; Wang, W.; Niu, Y.; Liu, T.; Li, L.; Zhang, M.; Li, Z.; Su, W.; Liu, F.; Zhang, X. A clinical extensively-drug resistant (XDR) Escherichia coli and role of Its β-Lactamase Genes. Front. Microbiol. 2020, 11, 590357. [Google Scholar] [CrossRef]
  42. Xu, J.; Zhu, Z.; Chen, Y.; Wang, W.; He, F. The plasmid-borne tet (A) gene is an important factor causing tigecycline resistance in ST11 carbapenem-resistant Klebsiella pneumoniae under selective pressure. Front. Microbiol. 2021, 12, 328. [Google Scholar] [CrossRef]
  43. Foong, W.E.; Wilhelm, J.; Tam, H.-K.; Pos, K.M. Tigecycline efflux in Acinetobacter baumannii is mediated by TetA in synergy with RND-type efflux transporters. J. Antimicrob. Chemother. 2020, 75, 1135–1139. [Google Scholar] [CrossRef]
  44. Enany, S.; Zakeer, S.; Diab, A.A.; Bakry, U.; Sayed, A.A. Whole genome sequencing of Klebsiella pneumoniae clinical isolates sequence type 627 isolated from Egyptian patients. PLoS ONE 2022, 17, e0265884. [Google Scholar] [CrossRef]
  45. Guo, Q.; Tomich, A.D.; McElheny, C.L.; Cooper, V.S.; Stoesser, N.; Wang, M.; Sluis-Cremer, N.; Doi, Y. Glutathione-S-transferase FosA6 of Klebsiella pneumoniae origin conferring fosfomycin resistance in ESBL-producing Escherichia coli. J. Antimicrob. Chemother. 2016, 71, 2460–2465. [Google Scholar] [CrossRef] [Green Version]
  46. Kieffer, N.; Poirel, L.; Mueller, L.; Mancini, S.; Nordmann, P. IS Ecp1-mediated transposition leads to fosfomycin and broad-spectrum cephalosporin resistance in Klebsiella pneumoniae. Antimicrob. Agents Chemother. 2020, 64, e00150-20. [Google Scholar] [CrossRef] [PubMed]
  47. de Man, T.J.; Lutgring, J.D.; Lonsway, D.R.; Anderson, K.F.; Kiehlbauch, J.A.; Chen, L.; Walters, M.S.; Sjölund-Karlsson, M.; Rasheed, J.K.; Kallen, A. Genomic analysis of a pan-resistant isolate of Klebsiella pneumoniae, United States 2016. mBio 2018, 9, e00440-18. [Google Scholar] [CrossRef] [Green Version]
  48. Liakopoulos, A.; Mevius, D.; Ceccarelli, D. A review of SHV extended-spectrum β-lactamases: Neglected yet ubiquitous. Front. Microbiol. 2016, 7, 1374. [Google Scholar] [CrossRef] [PubMed]
  49. Piazza, A.; Perini, M.; Mauri, C.; Comandatore, F.; Meroni, E.; Luzzaro, F.; Principe, L. Antimicrobial Susceptibility, Virulence, and Genomic Features of a Hypervirulent Serotype K2, ST65 Klebsiella pneumoniae Causing Meningitis in Italy. Antibiotics 2022, 11, 261. [Google Scholar] [CrossRef]
  50. Li, Q.; Zhu, J.; Kang, J.; Song, Y.; Yin, D.; Guo, Q.; Song, J.; Zhang, Y.; Wang, S.; Duan, J. Emergence of NDM-5-producing carbapenem-resistant Klebsiella pneumoniae and SIM-producing hypervirulent Klebsiella pneumoniae Isolated from aseptic body fluid in a large tertiary hospital, 2017–2018: Genetic traits of blaNDM-like and blaSIM-like genes as determined by NGS. Infect. Drug Resist. 2020, 13, 3075. [Google Scholar] [PubMed]
  51. Krapp, F.; Morris, A.R.; Ozer, E.A.; Hauser, A.R. Virulence characteristics of carbapenem-resistant Klebsiella pneumoniae strains from patients with necrotizing skin and soft tissue infections. Sci. Rep. 2017, 7, 13533. [Google Scholar] [CrossRef] [Green Version]
  52. Cubero, M.; Grau, I.; Tubau, F.; Pallarés, R.; Dominguez, M.; Linares, J.; Ardanuy, C. Hypervirulent Klebsiella pneumoniae clones causing bacteraemia in adults in a teaching hospital in Barcelona, Spain (2007–2013). Clin. Microbiol. Infect. 2016, 22, 154–160. [Google Scholar] [CrossRef] [Green Version]
  53. Fang, C.-T.; Chuang, Y.-P.; Shun, C.-T.; Chang, S.-C.; Wang, J.-T. A novel virulence gene in Klebsiella pneumoniae strains causing primary liver abscess and septic metastatic complications. J. Exp. Med. 2004, 199, 697–705. [Google Scholar] [CrossRef] [Green Version]
  54. Majdalani, N.; Gottesman, S. The Rcs phosphorelay: A complex signal transduction system. Annu. Rev. Microbiol. 2005, 59, 379–405. [Google Scholar] [CrossRef]
  55. Wan, B.; Zhang, Q.; Ni, J.; Li, S.; Wen, D.; Li, J.; Xiao, H.; He, P.; Ou, H.-y.; Tao, J. Type VI secretion system contributes to Enterohemorrhagic Escherichia coli virulence by secreting catalase against host reactive oxygen species (ROS). PLoS Pathog. 2017, 13, e1006246. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  56. Schroll, C.; Barken, K.B.; Krogfelt, K.A.; Struve, C. Role of type 1 and type 3 fimbriae in Klebsiella pneumoniae biofilm formation. BMC Microbiol. 2010, 10, 179. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  57. Jamal, M.; Ahmad, W.; Andleeb, S.; Jalil, F.; Imran, M.; Nawaz, M.A.; Hussain, T.; Ali, M.; Rafiq, M.; Kamil, M.A. Bacterial biofilm and associated infections. J. Chin. Med. Assoc. 2018, 81, 7–11. [Google Scholar] [CrossRef]
  58. Islam, M.M.; Kim, K.; Lee, J.C.; Shin, M. LeuO, a LysR-Type Transcriptional Regulator, Is Involved in Biofilm Formation and Virulence of Acinetobacter baumannii. Front. Cell. Infect. Microbiol. 2021, 11, 738706. [Google Scholar] [CrossRef] [PubMed]
  59. Srinivasan, V.B.; Mondal, A.; Venkataramaiah, M.; Chauhan, N.K.; Rajamohan, G. Role of oxyRKP, a novel LysR-family transcriptional regulator, in antimicrobial resistance and virulence in Klebsiella pneumoniae. Microbiology 2013, 159, 1301–1314. [Google Scholar] [CrossRef] [Green Version]
  60. Surgers, L.; Boyd, A.; Girard, P.-M.; Arlet, G.; Decré, D. ESBL-producing strain of hypervirulent Klebsiella pneumoniae K2, France. Emerg. Infect. Dis. 2016, 22, 1687. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  61. Osman, E.A.; El-Amin, N.; Adrees, E.A.; Al-Hassan, L.; Mukhtar, M. Comparing conventional, biochemical and genotypic methods for accurate identification of Klebsiella pneumoniae in Sudan. Access Microbiol. 2020, 2, acmi000096. [Google Scholar] [CrossRef] [PubMed]
  62. Kumabe, A.; Kenzaka, T. String test of hypervirulent Klebsiella pneumonia. QJM Int. J. Med. 2014, 107, 1053. [Google Scholar] [CrossRef] [Green Version]
  63. Sabeel, S.; Salih, M.A.; Ali, M.; El-Zaki, S.-E.; Abuzeid, N.; Elgadi, Z.A.M.; Altayb, H.N.; Elegail, A.; Ibrahim, N.Y.; Elamin, B.K. Phenotypic and genotypic analysis of multidrug-resistant Mycobacterium tuberculosis isolates from Sudanese patients. Tuberc. Res. Treat. 2017, 2017, 8340746. [Google Scholar]
  64. Mogana, R.; Adhikari, A.; Tzar, M.; Ramliza, R.; Wiart, C. Antibacterial activities of the extracts, fractions and isolated compounds from Canarium patentinervium Miq. against bacterial clinical isolates. BMC Complement. Med. Ther. 2020, 20, 55. [Google Scholar] [CrossRef] [Green Version]
  65. Kouidhi, B.; Zmantar, T.; Jrah, H.; Souiden, Y.; Chaieb, K.; Mahdouani, K.; Bakhrouf, A. Antibacterial and resistance-modifying activities of thymoquinone against oral pathogens. Ann. Clin. Microbiol. Antimicrob. 2011, 10, 29. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  66. Zerbino, D.R.; Birney, E. Velvet: Algorithms for de novo short read assembly using de Bruijn graphs. Genome Res. 2008, 18, 821–829. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  67. Tatusova, T.; DiCuccio, M.; Badretdin, A.; Chetvernin, V.; Nawrocki, E.P.; Zaslavsky, L.; Lomsadze, A.; Pruitt, K.D.; Borodovsky, M.; Ostell, J. NCBI prokaryotic genome annotation pipeline. Nucleic Acids Res. 2016, 44, 6614–6624. [Google Scholar] [CrossRef] [PubMed]
  68. Antipov, D.; Hartwick, N.; Shen, M.; Raiko, M.; Lapidus, A.; Pevzner, P.A. plasmidSPAdes: Assembling plasmids from whole genome sequencing data. Bioinformatics 2016, 32, 3380–3387. [Google Scholar] [CrossRef] [Green Version]
  69. Bortolaia, V.; Kaas, R.S.; Ruppe, E.; Roberts, M.C.; Schwarz, S.; Cattoir, V.; Philippon, A.; Allesoe, R.L.; Rebelo, A.R.; Florensa, A.F. ResFinder 4.0 for predictions of phenotypes from genotypes. J. Antimicrob. Chemother. 2020, 75, 3491–3500. [Google Scholar] [CrossRef]
  70. Liu, B.; Zheng, D.; Jin, Q.; Chen, L.; Yang, J. VFDB 2019: A comparative pathogenomic platform with an interactive web interface. Nucleic Acids Res. 2019, 47, D687–D692. [Google Scholar] [CrossRef]
  71. Lam, M.; Wick, R.R.; Watts, S.C.; Cerdeira, L.T.; Wyres, K.L.; Holt, K.E. A genomic surveillance framework and genotyping tool for Klebsiella pneumoniae and its related species complex. Nat. Commun. 2021, 12, 4188. [Google Scholar] [CrossRef]
  72. Struve, C.; Roe, C.C.; Stegger, M.; Stahlhut, S.G.; Hansen, D.S.; Engelthaler, D.M.; Andersen, P.S.; Driebe, E.M.; Keim, P.; Krogfelt, K.A. Mapping the evolution of hypervirulent Klebsiella pneumoniae. mBio 2015, 6, e00630-15. [Google Scholar] [CrossRef] [Green Version]
  73. Davis, J.J.; Wattam, A.R.; Aziz, R.K.; Brettin, T.; Butler, R.; Butler, R.M.; Chlenski, P.; Conrad, N.; Dickerman, A.; Dietrich, E.M. The PATRIC Bioinformatics Resource Center: Expanding data and analysis capabilities. Nucleic Acids Res. 2020, 48, D606–D612. [Google Scholar] [CrossRef] [Green Version]
  74. Xu, L.; Dong, Z.; Fang, L.; Luo, Y.; Wei, Z.; Guo, H.; Zhang, G.; Gu, Y.Q.; Coleman-Derr, D.; Xia, Q. OrthoVenn2: A web server for whole-genome comparison and annotation of orthologous clusters across multiple species. Nucleic Acids Res. 2019, 47, W52–W58. [Google Scholar] [CrossRef] [Green Version]
  75. Kwon, T.; Jung, Y.-H.; Lee, S.; Yun, M.-r.; Kim, W.; Kim, D.-W. Comparative genomic analysis of Klebsiella pneumoniae subsp. pneumoniae KP617 and PittNDM01, NUHL24835, and ATCC BAA-2146 reveals unique evolutionary history of this strain. Gut Pathog. 2016, 8, 34. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  76. Ramos, P.I.P.; Picão, R.C.; de Almeida, L.G.P.; Lima, N.C.B.; Girardello, R.; Vivan, A.C.P.; Xavier, D.E.; Barcellos, F.G.; Pelisson, M.; Vespero, E.C. Comparative analysis of the complete genome of KPC-2-producing Klebsiella pneumoniae Kp13 reveals remarkable genome plasticity and a wide repertoire of virulence and resistance mechanisms. BMC Genom. 2014, 15, 54. [Google Scholar] [CrossRef] [PubMed] [Green Version]
Antibiotics 11 00596 g001 550
Figure 1. Linear map of E. coli plasmid pECW602 which was detected in 9KP strain; the horizontal black lines indicate the length of the plasmid, the middle gray line contains information about plasmid length and coverage. In addition, the purple arrows indicate mobile elements and hypothetical proteins. The green arrows indicate ARGs.
Figure 1. Linear map of E. coli plasmid pECW602 which was detected in 9KP strain; the horizontal black lines indicate the length of the plasmid, the middle gray line contains information about plasmid length and coverage. In addition, the purple arrows indicate mobile elements and hypothetical proteins. The green arrows indicate ARGs.
Antibiotics 11 00596 g001
Antibiotics 11 00596 g002 550
Figure 2. Clustering of fimbrial proteins in contig 7 of K. pneumoniae 9KP; the horizontal black lines indicate the contig length, the green arrows indicate genes encoding fimbrial proteins, and the purple arrows indicate other genes located at the same contig.
Figure 2. Clustering of fimbrial proteins in contig 7 of K. pneumoniae 9KP; the horizontal black lines indicate the contig length, the green arrows indicate genes encoding fimbrial proteins, and the purple arrows indicate other genes located at the same contig.
Antibiotics 11 00596 g002
Antibiotics 11 00596 g003 550
Figure 3. Clustering enterobactin proteins in contig 32 of K. pneumoniae 9KP; the horizontal black lines indicate the contig length, the green arrows indicate genes encoding enterobactin proteins, and the purple arrows indicate other genes located at the same contig.
Figure 3. Clustering enterobactin proteins in contig 32 of K. pneumoniae 9KP; the horizontal black lines indicate the contig length, the green arrows indicate genes encoding enterobactin proteins, and the purple arrows indicate other genes located at the same contig.
Antibiotics 11 00596 g003
Antibiotics 11 00596 g004 550
Figure 4. Phylogenomics analysis of K. pneumoniae 9KP (shown in red highlight) compared to African K. pneumoniae strains. Strain 3KE is K. quasipneumoniae used as an outgroup. Numbers in nodes indicate Pasteur MLST isolate IDs.
Figure 4. Phylogenomics analysis of K. pneumoniae 9KP (shown in red highlight) compared to African K. pneumoniae strains. Strain 3KE is K. quasipneumoniae used as an outgroup. Numbers in nodes indicate Pasteur MLST isolate IDs.
Antibiotics 11 00596 g004
Table
Table 1. Antimicrobial susceptibility testing of selected antimicrobial agents used against 9KP strain.
Table 1. Antimicrobial susceptibility testing of selected antimicrobial agents used against 9KP strain.
AntibioticInhibition Zone (mm)MIC (μg/mL)Susceptibility a
ciprofloxacin12128R
ceftazidime10-R
cefotaxime10128R
trimethoprim-sulfamethoxazoleNo inhibition-R
cephalexin10-R
nitrofurantoin10-R
amoxicillin-clavulanic acidNo inhibition-R
ampicillinNo inhibition 1024R
tetracycline-256R
meropenem32-S
imipenem30-S
amikacin20-S
gentamicin204S
chloramphenicol-4S
Abbreviation: R = Resistant, S = Sensitive, - = Not tested, mm = millimeter; a Antimicrobial susceptibility testing determined according to CLSI guidelines [30].
Table
Table 2. Comparison of virulence factors of K. pneumoniae 9KP with other control strains (K. pneumoniae 342, MGH 78578, NTUH-K2044, 1084, HS11286, JM45, KCTC 2242, SB3432) and the most related strains (kkp066, kkp0e6, and 23KE).
Table 2. Comparison of virulence factors of K. pneumoniae 9KP with other control strains (K. pneumoniae 342, MGH 78578, NTUH-K2044, 1084, HS11286, JM45, KCTC 2242, SB3432) and the most related strains (kkp066, kkp0e6, and 23KE).
Virulence FactorRelated Genes9KP342MGH78578NTUH-K20441084HS11286JM45KCTC 2242SB3432kkp066kkp0e6kkp0e723KE
Adherence
Type 3 fimbriae8++7++++++++ 7 +
Type I fimbriae10+++++++++99 8 +
Type IV pili121---------- - -
Antiphagocytosis
Capsule1+++++++++++++
Efflux pump
AcrAB2+++++++++1+++
Iron uptake
Aerobactin5111+111++1 1 1 1
Ent siderophore1312+++++12+-12 10 11 +
Salmochelin5222+422242 2 2 2
Yersiniabactin11---+++---- + + -
Nutritional factor
Allantoin utilization6---++----+ - - -
Regulation
RcsAB2++++++++++ + + +
RmpA1---+---+-1 - 1 -
Secretion system
T6SS-I181311111313+++1016 15 15 12
T6SS-II109+81111-41 1 - 1
T6SS-III1812+1114131413141110 8 5 12
Sci-I T6SS271--------- - - -
Serum resistance
LPS rfb locus1+++++++++++ + -
Toxin
Colibactin18----+-------+
Key: + means the presence of the same number of genes, - means gene absent, numbers in tables indicate numbers of virulence-factors-related genes.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Altayb, H.N.; Elbadawi, H.S.; Baothman, O.; Kazmi, I.; Alzahrani, F.A.; Nadeem, M.S.; Hosawi, S.; Chaieb, K. Genomic Analysis of Multidrug-Resistant Hypervirulent (Hypermucoviscous) Klebsiella pneumoniae Strain Lacking the Hypermucoviscous Regulators (rmpA/rmpA2). Antibiotics 2022, 11, 596. https://doi.org/10.3390/antibiotics11050596

AMA Style

Altayb HN, Elbadawi HS, Baothman O, Kazmi I, Alzahrani FA, Nadeem MS, Hosawi S, Chaieb K. Genomic Analysis of Multidrug-Resistant Hypervirulent (Hypermucoviscous) Klebsiella pneumoniae Strain Lacking the Hypermucoviscous Regulators (rmpA/rmpA2). Antibiotics. 2022; 11(5):596. https://doi.org/10.3390/antibiotics11050596

Chicago/Turabian Style

Altayb, Hisham N., Hana S. Elbadawi, Othman Baothman, Imran Kazmi, Faisal A. Alzahrani, Muhammad Shahid Nadeem, Salman Hosawi, and Kamel Chaieb. 2022. "Genomic Analysis of Multidrug-Resistant Hypervirulent (Hypermucoviscous) Klebsiella pneumoniae Strain Lacking the Hypermucoviscous Regulators (rmpA/rmpA2)" Antibiotics 11, no. 5: 596. https://doi.org/10.3390/antibiotics11050596

APA Style

Altayb, H. N., Elbadawi, H. S., Baothman, O., Kazmi, I., Alzahrani, F. A., Nadeem, M. S., Hosawi, S., & Chaieb, K. (2022). Genomic Analysis of Multidrug-Resistant Hypervirulent (Hypermucoviscous) Klebsiella pneumoniae Strain Lacking the Hypermucoviscous Regulators (rmpA/rmpA2). Antibiotics, 11(5), 596. https://doi.org/10.3390/antibiotics11050596

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop